NEWS

Princeton, NJ, November 6, 2007 — JFK Communications, Inc., a Princeton-based healthcare public relations firm, welcomes Maureen Miller as senior account executive. 

Miller will support key pharmaceutical and biotechnology accounts, including Eisai Inc. and Cytogen Corporation.  In this capacity, she will develop strategic recommendations and manage program implementation including product public relations, corporate communications and advocacy relations.  JFK Communications, Inc. is currently agency of record for Eisai’s emerging oncology business and supports all of Cytogen’s product and corporate public relations. 

Prior to joining JFK Communications, Miller worked at Dorland Global Public Relations, where she played a key role supporting public relations programs for leading pharmaceutical and biotechnology clients including Centocor.  Miller was part of an account team providing advocacy support,  spokesperson development  and national media outreach to support Remicadeâ (infliximab), Centocor’s treatment for rheumatoid arthritis, Crohn’s disease and other immune-mediated inflammatory diseases.

Miller graduated from Rowan University with a bachelor’s degree in communications and participated in the American Association of Advertising Agencies Institute of Advanced Advertising Studies (IAAS), a program for promising agency professionals.  Miller is a member of the Public Relations Society of America.

JFK Communications, Inc. provides innovative public relations solutions for the pharmaceutical, biotechnology and medical technology industries.  For more information on JFK Communications’ capabilities or career opportunities, please visit www.jfkhealth.com or call (609) 514-5117.